New drugs and medical devices depend on clinical research and trials to make it to market. This rapidly expanding area continues to attract academic institutions and health systems, as well as private physicians, site maintenance organizations and clinical research organizations. The contracts between the parties to frame these trials can be difficult and complicated.
In addition, trials supported by the National Institutes of Health or other government agency or grant must have trial documentation that is carefully crafted to ensure regulatory compliance, protect intellectual property interests and minimize business liability exposure.
Attorneys on Husch Blackwell’s Healthcare team understand the relationships among various stakeholders, and have extensive experience in a variety of areas, including intellectual property, life sciences and federal regulations. We work together to provide a cohesive and integrated approach for our clients.
Your Husch Blackwell team can help with: